Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
update Author Content to PENDING |
No edit summary |
||
| Line 979: | Line 979: | ||
|SP (prior AE), 2021 template added | |SP (prior AE), 2021 template added | ||
|- | |- | ||
|B-cell Prolymphocytic Leukemia||Disease|| | |B-cell Prolymphocytic Leukemia||Disease||NOT NEEDED. DO NOT ASSIGN | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
|SP (prior AE); 2021 template added; No longer an entity | |SP (prior AE); 2021 template added; No longer an entity | ||
| Line 1,219: | Line 1,219: | ||
|SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later) | |SP (prior AE); has prior content in old template but same name in 5th edition - Rachel working on this outside of production site with new template to replace production site page later) | ||
|- | |- | ||
| Testicular Follicular Lymphoma|| || | | Testicular Follicular Lymphoma|| ||NOT NEEDED. DO NOT ASSIGN. | ||
| | | | ||
| | | | ||
| Line 1,939: | Line 1,939: | ||
| | | | ||
|- | |- | ||
| Monomorphic T/NK-cell PTLD||Disease|| | | Monomorphic T/NK-cell PTLD||Disease||NOT NEEDED. DO NOT ASSIGN. | ||
| | | | ||
| | | | ||
| | | | ||
| || | | || | ||
| | | | ||
| | | | ||